Avenue Therapeutics, Inc. PNK:ATXI
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2024-12-31 · prior 2024-09-30.
New Positions(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 140,000 | +140,000 | $280.0K | +$280.0K | — |
| BOOTHBAY FUND MANAGEMENT, LLC | 41,089 | +41,089 | $82.2K | +$82.2K | — |
| SBI Securities Co., Ltd. | 9 | +9 | $18 | +$18 | — |
Added To(4)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 3,096 | +1,356 | $6.2K | +$1.9K | 77.9% |
| UBS Group AG | 7,920 | +1,777 | $15.8K | +$544 | 28.9% |
| JPMORGAN CHASE & CO | 2 | +1 | $7 | +$4 | 100.0% |
| BANK OF AMERICA CORP /DE/ | 14 | +4 | $28 | +$3 | 40.0% |
Reduced(2)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | 500 | -61 | $1.0K | -$397 | -10.9% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | 0 | $0 | $0 | — |
Sold Out(4)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 0 | -115,000 | $0 | -$286.4K | — |
| SABBY MANAGEMENT, LLC | 0 | -63,060 | $0 | -$157.0K | — |
| Moss Adams Wealth Advisors LLC | 0 | -11,000 | $0 | -$27.4K | — |
| Royal Bank of Canada | 0 | -8 | $0 | $0 | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2024-12-31.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| Ikarian Capital, LLC | 140,000 | $280.0K | +140,000 | — |
| BOOTHBAY FUND MANAGEMENT, LLC | 41,089 | $82.2K | +41,089 | — |
| UBS Group AG | 7,920 | $15.8K | +1,777 | 28.9% |
| Tower Research Capital LLC (TRC) | 3,096 | $6.2K | +1,356 | 77.9% |
| WELLS FARGO & COMPANY/MN | 500 | $1.0K | -61 | -10.9% |
| BANK OF AMERICA CORP /DE/ | 14 | $28 | +4 | 40.0% |
| SBI Securities Co., Ltd. | 9 | $18 | +9 | — |
| JPMORGAN CHASE & CO | 2 | $7 | +1 | 100.0% |
New & Closed Positions this quarter
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for ATXI against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.